|
CEP170 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.776100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.589000E-04 |
| Normal-vs-Stage2 |
2.429800E-04 |
| Normal-vs-Stage3 |
1.204390E-03 |
| Normal-vs-Stage4 |
7.842200E-03 |
| Stage1-vs-Stage2 |
8.712100E-02 |
| Stage1-vs-Stage3 |
5.600000E-01 |
| Stage1-vs-Stage4 |
6.501400E-01 |
| Stage2-vs-Stage3 |
2.461800E-01 |
| Stage2-vs-Stage4 |
3.325800E-01 |
| Stage3-vs-Stage4 |
9.880400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.834300E-04 |
| Normal-vs-AfricanAmerican |
2.040600E-01 |
| Normal-vs-Asian |
3.461500E-03 |
| Caucasian-vs-AfricanAmerican |
4.372200E-01 |
| Caucasian-vs-Asian |
4.414600E-01 |
| AfricanAmerican-vs-Asian |
2.598400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.096360E-02 |
| Normal-vs-Female |
5.66169999999255E-05 |
| Male-vs-Female |
3.730800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.981500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.571250E-04 |
| Normal-vs-Age(61-80Yrs) |
1.183590E-03 |
| Normal-vs-Age(81-100Yrs) |
9.164400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.872010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.775000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.625200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.481800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.969600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.375570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.798600E-01 |
| Classical-VS-Follicular |
1.223740E-02 |
| Classical-VS-Other |
4.307200E-01 |
| Classical-VS-Normal |
3.877100E-03 |
| Tall-VS-Follicular |
3.966400E-01 |
| Tall-VS-Other |
6.741400E-01 |
| Tall-VS-Normal |
4.495900E-03 |
| Follicular-VS-Other |
9.532600E-01 |
| Follicular-VS-Normal |
1.207140E-04 |
| Other-VS-Normal |
8.807700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.924700000002E-05 |
| Normal-vs-N1 |
3.481800E-02 |
| N0-vs-N1 |
4.281900E-02 |
|
|
